BiVictriX Therapeutics Plc (BVX.L)

GBp 10.0

(17.65%)

Operating Expenses Summary of BiVictriX Therapeutics Plc

  • BiVictriX Therapeutics Plc's latest annual operating expenses in 2023 was 2.86 Million GBP , down -3.87% from previous year.
  • BiVictriX Therapeutics Plc's latest quarterly operating expenses in 2024 Q2 was 1.58 Million GBP , up 2.52% from previous quarter.
  • BiVictriX Therapeutics Plc reported a annual operating expenses of 2.97 Million GBP in annual operating expenses 2022, up 98.07% from previous year.
  • BiVictriX Therapeutics Plc reported a annual operating expenses of 1.5 Million GBP in annual operating expenses 2021, up 188.29% from previous year.
  • BiVictriX Therapeutics Plc reported a quarterly operating expenses of 1.31 Million GBP for 2023 Q2, up 1.31% from previous quarter.
  • BiVictriX Therapeutics Plc reported a quarterly operating expenses of 2.86 Million GBP for 2023 FY, down -3.87% from previous quarter.

Annual Operating Expenses Chart of BiVictriX Therapeutics Plc (2023 - 2018)

Historical Annual Operating Expenses of BiVictriX Therapeutics Plc (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 2.86 Million GBP -3.87%
2022 2.97 Million GBP 98.07%
2021 1.5 Million GBP 188.29%
2020 521 Thousand GBP -0.95%
2019 526 Thousand GBP 9.58%
2018 480 Thousand GBP 0.0%

Peer Operating Expenses Comparison of BiVictriX Therapeutics Plc

Name Operating Expenses Operating Expenses Difference